These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 9391166)

  • 1. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor.
    Gehm BD; McAndrews JM; Chien PY; Jameson JL
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14138-43. PubMed ID: 9391166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
    Wietzke JA; Welsh J
    J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogenic activity in white and red wine extracts.
    Klinge CM; Risinger KE; Watts MB; Beck V; Eder R; Jungbauer A
    J Agric Food Chem; 2003 Mar; 51(7):1850-7. PubMed ID: 12643641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic compounds of wine: the phytoestrogen resveratrol and moderate red wine consumption during menopause.
    Calabrese G
    Drugs Exp Clin Res; 1999; 25(2-3):111-4. PubMed ID: 10370872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavonoid effects relevant to cancer.
    Brownson DM; Azios NG; Fuqua BK; Dharmawardhane SF; Mabry TJ
    J Nutr; 2002 Nov; 132(11 Suppl):3482S-3489S. PubMed ID: 12421874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
    Bowers JL; Tyulmenkov VV; Jernigan SC; Klinge CM
    Endocrinology; 2000 Oct; 141(10):3657-67. PubMed ID: 11014220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase.
    Wallerath T; Deckert G; Ternes T; Anderson H; Li H; Witte K; Förstermann U
    Circulation; 2002 Sep; 106(13):1652-8. PubMed ID: 12270858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
    Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
    Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture.
    Zava DT; Blen M; Duwe G
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):637-45. PubMed ID: 9168008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assaying the estrogenicity of phytoestrogens in cells of different estrogen sensitive tissues.
    Schmitt E; Dekant W; Stopper H
    Toxicol In Vitro; 2001; 15(4-5):433-9. PubMed ID: 11566575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms.
    Collins-Burow BM; Burow ME; Duong BN; McLachlan JA
    Nutr Cancer; 2000; 38(2):229-44. PubMed ID: 11525602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
    Bhat KP; Pezzuto JM
    Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER alpha.
    Levenson AS; Gehm BD; Pearce ST; Horiguchi J; Simons LA; Ward JE; Jameson JL; Jordan VC
    Int J Cancer; 2003 May; 104(5):587-96. PubMed ID: 12594813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytoestrogens act as estrogen agonists in an estrogen-responsive pituitary cell line.
    Stahl S; Chun TY; Gray WG
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):41-8. PubMed ID: 9772198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol.
    Basly JP; Marre-Fournier F; Le Bail JC; Habrioux G; Chulia AJ
    Life Sci; 2000 Jan; 66(9):769-77. PubMed ID: 10698352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol and red wine consumption.
    Slater I; Odum J; Ashby J
    Hum Exp Toxicol; 1999 Oct; 18(10):625-6. PubMed ID: 10557014
    [No Abstract]   [Full Text] [Related]  

  • 17. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro.
    Zava DT; Duwe G
    Nutr Cancer; 1997; 27(1):31-40. PubMed ID: 8970179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogenic activity of naturally occurring anthocyanidins.
    Schmitt E; Stopper H
    Nutr Cancer; 2001; 41(1-2):145-9. PubMed ID: 12094617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogenic effects of resveratrol in breast cancer cells expressing mutant and wild-type estrogen receptors: role of AF-1 and AF-2.
    Gehm BD; Levenson AS; Liu H; Lee EJ; Amundsen BM; Cushman M; Jordan VC; Jameson JL
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):223-34. PubMed ID: 15120416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells.
    Tamir S; Eizenberg M; Somjen D; Stern N; Shelach R; Kaye A; Vaya J
    Cancer Res; 2000 Oct; 60(20):5704-9. PubMed ID: 11059763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.